Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic β-cell area
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Introduction: Hyperproinsulinaemia has been reported in patients with type 2 diabetes. It is unclear whether this is due to an intrinsic defect in β-cell function or secondary to the increased demand on the β-cells. We investigated whether hyperproinsulinaemia is also present in patients with secondary diabetes, and whether proinsulin levels are associated with impaired β-cell area or function. Patients and methods: Thirty-three patients with and without diabetes secondary to pancreatic diseases were studied prior to pancreatic surgery. Intact and total proinsulin levels were compared with the pancreatic β-cell area and measures of insulin secretion and action. Results: Fasting concentrations of total and intact proinsulin were similar in patients with normal, impaired (including two cases of impaired fasting glucose) and diabetic glucose tolerance (P=0.58 and P=0.98 respectively). There were no differences in the total proinsulin/insulin or intact proinsulin/insulin ratio between the groups (P=0.23 and P=0.71 respectively). There was a weak inverse association between the total proinsulin/insulin ratio and pancreatic β-cell area (r2=0.14,P=0.032), whereas the intact proinsulin/insulin ratio and the intact and total proinsulin levels were unrelated to β-cell area. However, a strong inverse relationship between homeostasis model assessment index of β-cell function and both the total and the intact proinsulin/insulin ratio was found (r2=0.55 and r2=0.48 respectively). The association of insulin resistance (IR) with intact proinsulin was much weaker than the correlation with fasting insulin. Conclusions: Hyperproinsulinaemia is associated with defects in insulin secretion rather than a reduction in β-cell area. The weak association between intact proinsulin and IR argues against the usefulness of this parameter in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperproinsulinemia has been reported in both T2D patients and individuals with prediabetes, suggesting that defective islet beta-cell insulin processing is integral to the early stages of disease pathology.101,102”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [101]
In the citing paper
“In healthy subjects, proinsulin accounts for up to 20% of the insulin levels in circulation, but in T2D this value can reach up to 50% and total proinsulin levels have shown to be higher in T2D patients than healthy controls, which suggests that dysfunctional processing and secretion of insulin by the remaining islet beta-cell population further contributes to the decreased insulin levels observed”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [101]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503
Self-citationPathologic anatomy of the pancreas in juvenile diabetes mellitus
Gepts, W. (1965) · Diabetes · doi:10.2337/diab.14.10.619 · Cited by 1,345
Clark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 649
Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus Revisited
Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. U. (1985) · Pathology and Immunopathology Research · doi:10.1159/000156969 · Cited by 577
Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572
Meier, J. J., Bhushan, A., Butler, A. E., Rizza, R. A., & Butler, P. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1949-2 · Cited by 493
Self-citationRøder, M. E., Porte, D., Schwartz, R. S., & Kahn, S. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4544 · Cited by 207
Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction?
Porte, D., & Kahn, S. E. (1989) · Diabetes · doi:10.2337/diab.38.11.1333 · Cited by 185
Disproportionately Elevated Proinsulin in Pima Indians with Noninsulin-Dependent Diabetes Mellitus*
SAAD, M. F., KAHN, S. E., NELSON, R. G., PETTITT, D. J., KNOWLER, W. C., SCHWARTZ, M. W., KOWALYK, S., BENNETT, P. H., & PORTE, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1247 · Cited by 167
Roder, M. E. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.604 · Cited by 165
Functional Assessment of Pancreatic β-Cell Area in Humans
Meier, J. J., Menge, B. A., Breuer, T. G. K., Müller, C. A., Tannapfel, A., Uhl, W., Schmidt, W. E., & Schrader, H. (2009) · Diabetes · doi:10.2337/db08-1611 · Cited by 163
Self-citationBeta cell mass in diabetes: a realistic therapeutic target?
Meier, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-0936-9 · Cited by 155
Self-citationFasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes
Pfützner, A., Kunt, T., Hohberg, C., Mondok, A., Pahler, S., Konrad, T., Lübben, G., & Forst, T. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.682 · Cited by 149
Proinsulin as a marker for the development of NIDDM in Japanese-American men
Kahn, S. E., Leonetti, D. L., Prigeon, R. L., Boyko, E. J., Bergstrom, R. W., & Fujimoto, W. Y. (1995) · Diabetes · doi:10.2337/diabetes.44.2.173 · Cited by 138
Proinsulin as a Marker for the Development of NIDDM in Japanese-American Men
Kahn, S. E., Leonetti, D. L., Prigeon, R. L., Boyko, E. J., Bergstrom, R. W., & Fujimoto, W. Y. (1995) · Diabetes · doi:10.2337/diab.44.2.173 · Cited by 137
Laedtke, T., Kjems, L., Pørksen, N., Schmitz, O., Veldhuis, J., Kao, P. C., & Butler, P. C. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e520 · Cited by 133
β-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes
Festa, A., Williams, K., Hanley, A. J. G., & Haffner, S. M. (2008) · Diabetes · doi:10.2337/db07-0954 · Cited by 128
Reduced Pancreatic Volume and β-Cell Area in Patients With Chronic Pancreatitis
Schrader, H., Menge, B. A., Schneider, S., Belyaev, O., Tannapfel, A., Uhl, W. H., Schmidt, W. E., & Meier, J. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.083 · Cited by 120
Self-citationWhy Does Ethnicity Affect Prevalence of Gestational Diabetes? The Underwater Volcano Theory
Yue, D. K., Molyneaux, L. M., Ross, G. P., Constantino, M. I., Child, A. G., & Turtle, J. R. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199608)13:8<748::aid-dia164>3.0.co;2-i · Cited by 101
Mykkänen, L., Haffner, S. M., Hales, C. N., Rönnemaa, T., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.12.1990 · Cited by 92
Mykkanen, L., Haffner, S. M., Hales, C. N., Ronnemaa, T., & Laakso, M. (1997) · Diabetes · doi:10.2337/diabetes.46.12.1990 · Cited by 92
Seaquist, E. R., Kahn, S. E., Clark, P. M., Hales, C. N., Porte, D., & Robertson, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118435 · Cited by 89
Mykkänen, L., Zaccaro, D. J., Hales, C. N., Festa, A., & Haffner, S. M. (1999) · Diabetologia · doi:10.1007/s001250051271 · Cited by 77
Røder, M. E., Knip, M., HARTLING, S. G., Karjalainen, J., Åkerblom, H. K., & Binder, C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989457 · Cited by 77
Røder, M. E., Dinesen, B., Hartling, S. G., Houssa, P., Vestergaard, H., Sodoyez-Goffaux, F., & Binder, C. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.609 · Cited by 64
Sjoberg, R. J., & Kidd, G. S. (1989) · Diabetes Care · doi:10.2337/diacare.12.10.715 · Cited by 56
Smith, S. A., Porter, L. E., Biswas, N., & Freed, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0705 · Cited by 54
Role of Intact Proinsulin in Diagnosis and Treatment of Type 2 Diabetes Mellitus
Pfützner, A., Pfützner, A. H., Larbig, M., & Forst, T. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504774198124 · Cited by 52
Impact of Sitagliptin on Markers of β-cell Function: A Meta-Analysis
Riche, D. M., East, H. E., & Riche, K. D. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31818eb721 · Cited by 44
Kahn, S. E., McCulloch, D. K., Schwartz, M. W., Palmer, J., & Porte, D. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.1.1727820 · Cited by 40
Relative Hypersecretion of Proinsulin in Rat Model of NIDDM
Leahy, J. L., Halban, P. A., & Weir, G. C. (1991) · Diabetes · doi:10.2337/diab.40.8.985 · Cited by 37
Pfützner, A., Standl, E., Hohberg, C., Konrad, T., Strotmann, H.-J., Lübben, G., Langenfeld, M. R. W., Schulze, J., & Forst, T. M. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.478 · Cited by 30
Davies, M. J., Metcalfe, J., Day, J., Grenfell, A., Hales, C. N., & Gray, I. P. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00274.x · Cited by 27
Survey and Synthesis of Pathology Research
(2017) · Survey and Synthesis of Pathology Research · doi:10.1159/issn.0253-438x · Cited by 22
Davies, M. J., Metcalfe, J., Day, J. L., Grenfell, A., Hales, C. N., & Gray, I. P. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00233.x · Cited by 21
Pfützner, A., Weber, M. M., & Forst, T. M. (2008) · PubMed · Cited by 19
Røder, M. E. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1570 · Cited by 15
Røder, M. E., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s22 · Cited by 10
Stickle, D. F., Reynolds, M. A., Morris, M. D., & Quon, M. J. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00072-8 · Cited by 5
Research works printed but not linked: 4
- Pfutzner, 2008, Clinical laboratory, 54, 485
- Clark, 1988, Diabetes research (Edinburgh, Lothian), 9, 151
- Nagi, 1996, Diabetic medicine : a journal of the British Diabetic Association, 13, 753, 10.1002/(sici)1096-9136(199608)13:8<753::aid-dia163>3.0.co;2-z · DOI · Paper page
- Kahn, 1992, Journal of Clinical Endocrinology & Metabolism, 74, 192, 10.1210/jc.74.1.192 · doi:10.1210/jc.74.1.192
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Misfolded proteins in Alzheimer's disease and type II diabetes
DeToma, A. S., Salamekh, S., Ramamoorthy, A., & Lim, M. H. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15112f · Cited by 361
Nieuwoudt, S., Fealy, C. E., Foucher, J. A., Scelsi, A. R., Malin, S. K., Pagadala, M., Rocco, M., Burguera, B., & Kirwan, J. P. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00407.2016 · Cited by 87
“Insulin processing was calculated as the ratio of proinsulin to insulin (6).”
MethodThe β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
“Prolonged increased secretory demand in the face of reduced β-cell mass created by a hemi-pancreatectomy in humans has been associated with an increase in proinsulin:insulin in those at increased risk of diabetes (411), but not in those without diabetes or a risk thereof (412, 413).”
BackgroundVangipurapu, J., Stančáková, A., Kuulasmaa, T., Kuusisto, J., & Laakso, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124028 · Cited by 46
Metadata
- Authors
- Breuer, T. G. K., Menge, B. A., Banasch, M., Uhl, W., Tannapfel, A., Schmidt, W. E., Nauck, M. A., & Meier, J. J.
- Affiliations
- St. Josef-Hospital (DE)
- Ruhr University Bochum (DE)
- Diabeteszentrum Bad Lauterberg (DE)
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 163
- Issue
- 4
- Pages
- 551-558
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2110001745
- Cited by
- 20
- References
- 42
- Citations by year
- 2026: 1 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2015: 2 · 2013: 1 · 2012: 1
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- proinsulin, secondary diabetes, pancreatic diseases, beta-cell function, insulin secretion, insulin resistance, HOMA-β, proinsulin/insulin ratio, impaired fasting glucose, pancreatic surgery
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Female, Humans, Insulin, Insulin Resistance, Male, Pancreatic Diseases, Proinsulin, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.